CANNAPHARMARX, INC. (CPMD) Return on equity 2019–2022
CANNAPHARMARX, INC. (CPMD) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-49.2%FY2022 · since FY2019: -421.3% → -49.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -49.2% | — |
| FY2019 | -421.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice